Blood · 1997 · 398 citations · 57 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyHemostasisBleeding Disorder ManagementBleeding DisordersGastrointestinal Bleeding ManagementHemostasis ManagementHemostatic AgentsPrimary Bleeding Disorders
IN 1977 DESMOPRESSIN (1-deamino-8-D-arginine vasopressin, abbreviated DDAVP), a derivative of the antidiuretic hormone, was used for the first time to treat patients with hemophilia A and von Willebrand disease (vWD), the most frequent congenital bleeding disorders.[1][1] After the original clinical
57
A double‐blind, placebo‐controlled trial
Robert S. Pinals, Stanley B. Kaplan, Jeffrey G. Lawson et al. · Arthritis & Rheumatism · 1986 · 1.4K citations
IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK
JeromeL. Sullivan · The Lancet · 1981 · 979 citations
Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia
Pier Mannuccio Mannucci, Giuseppe Remuzzi, F Pusineri et al. · New England Journal of Medicine · 1983 · 612 citations
Medicine, Hematology, Pharmacology +17
Joel L. Moake, NA Turner, NA Stathopoulos et al. · Journal of Clinical Investigation · 1986 · 610 citations · Full text
Medicine, Cell Biology, Hematology +17